tag:blogger.com,1999:blog-74041157204387164952009-12-16T15:39:00.069+13:00Open access journals, science, and the publishing businessTom Hillhttp://www.blogger.com/profile/14499465026739684247tom.hill@la-press.comBlogger296125LibertasAcademicahttp://feedburner.google.comtag:blogger.com,1999:blog-7404115720438716495.post-37891444564688901272009-12-09T17:15:00.003+13:002009-12-10T12:13:18.261+13:002009-12-10T12:13:18.261+13:00<span style="font-weight: bold;">Week 49 (30 November)</span><br /><ul><li><a href="http://la-press.com/article.php?article_id=1751">Osler-Weber-Rendu (OWR) Disease and Heart Failure<br /><br /></a></li><li><a href="http://la-press.com/article.php?article_id=1750">Calcitriol in the Management of Moderate to Severe Plaque Psoriasis<br /><br /></a></li><li><a href="http://la-press.com/article.php?article_id=1752">Stratification of Antigen-presenting Cells within the Normal Cornea</a></li></ul><span style="font-weight: bold;">Week 48 (23-29 November)</span><br /><ul><li><a href="http://la-press.com/article.php?article_id=1742">Retinal Ganglion Cell Loss in Diabetes Associated with Elevated Homocysteine<br /><br /></a></li><li><a href="http://la-press.com/article.php?article_id=1744">In silico Analysis of Human Telomerase Reverse Transcriptase (hTERT ) Gene: Identification of a Distant Homolog of Melanoma Antigen Family Gene (MAGE)</a><br /><br /></li><li><a href="http://la-press.com/article.php?article_id=1743">Safety and Efficacy of Ivabradine in the Management of Stable Angina Pectoris<br /><br /></a></li><li><a href="http://la-press.com/article.php?article_id=1747">Adjuvant Chemotherapy for Patients with Stage III Colon Cancer: Results from a CDC-NPCR Patterns of Care Study<br /><br /></a></li><li><a href="http://la-press.com/article.php?article_id=1746">Review of Omega-3 Fatty Acids for the Treatment of Attention Deficit/Hyperactivity Disorder<br /><br /></a></li><li><a href="http://la-press.com/article.php?article_id=1749">Doty’s Method (Two Sinus Reconstructions) of Supravalvular Aortic Stenosis in Williams’s Syndrome<br /><br /></a></li><li><a href="http://la-press.com/article.php?article_id=1745">Pharmacotherapy Update on the Treatment of Overactive Bladder Syndrome: Focus on Fesoterodine<br /><br /></a></li><li><a href="http://la-press.com/article.php?article_id=1748">Dexlansoprazole MR in the Management of Gastroesophageal Reflux Disease<br /><br /></a></li><li><a href="http://la-press.com/article.php?article_id=1739">Anterior Chamber-Associated Immune Deviation (ACAID): An Acute Response to Ocular Insult Protects from Future Immune-Mediated Damage?</a></li></ul><span style="font-weight: bold;">Week 47 (16-22 November)</span><span style="text-decoration: underline;"><br /></span><ul><li><a href="http://la-press.com/article.php?article_id=1735">Discrimination of Carcinogens by Hepatic Transcript Profiling in Rats Following 28-day Administration<br /><br /></a></li><li> <a href="http://la-press.com/article.php?article_id=1737">The Knowledge and Attitudes of University Students Concerning HPV Vaccine and Cervical Screening<br /><br /></a></li><li> <a href="http://la-press.com/article.php?article_id=1738">Eating Disorder Symptoms and Alcohol Use Among Adolescents in Substance Abuse Treatment<br /><br /></a></li><li> <a href="http://la-press.com/article.php?article_id=1741">An Efficient Method to Identify Conditionally Activated Transcription Factors and their Corresponding Signal Transduction Pathway Segments<br /><br /></a></li><li> <a href="http://la-press.com/article.php?article_id=1740">Pharmacotherapy of Fibromyalgia: Focus on Duloxetine<br /><br /></a></li><li> <a href="http://la-press.com/article.php?article_id=1736">Principles of MMT<br /><br /></a></li><li> <a href="http://la-press.com/article.php?article_id=1720">Pharmacotherapy of Micafungin: Clinical Review</a></li></ul><span style="text-decoration: underline;"></span><span style="font-weight: bold;">Week 46 (9-15 November)</span><br /><ul><li><a href="http://la-press.com/article.php?article_id=1727">Proteasome Inhibition: Thinking Outside the Box<br /><br /></a></li><li><a href="http://la-press.com/article.php?article_id=1725">Trends in Developmental, Behavioral and Somatic Factors by Diagnostic Sub-group in Pervasive Developmental Disorders: A Follow-up Analysis<br /><br /></a></li><li><a href="http://la-press.com/article.php?article_id=1724">Assessing the Status of Environmental Education in Illinois Elementary Schools<br /><br /></a></li><li><a href="http://la-press.com/article.php?article_id=1726">Diffusion-exchange weighted imaging<br /><br /></a></li><li><a href="http://la-press.com/article.php?article_id=1729">Prospect of Adipose Tissue Derived Mesenchymal Stem Cells in Regenerative Medicine<br /><br /></a></li><li><a href="http://la-press.com/article.php?article_id=1728">Fighting the Battle Against Infectious Diseases: Contributions of Selected Social Science Disciplines<br /><br /></a></li><li><a href="http://la-press.com/article.php?article_id=1731">Safety and Efficacy of Cefazolin Sodium in the Management of Bacterial Infection and in Surgical Prophylaxis<br /><br /></a></li><li><a href="http://la-press.com/article.php?article_id=1733">Characterization of a Test for Invasive Breast Cancer Using X-ray Diffraction of Hair—Results of a clinical Trial<br /><br /></a></li><li><a href="http://la-press.com/article.php?article_id=1732">Increased Detection of Breast Cancer Virus Sequences in Inflammatory Breast Cancer<br /><br /></a></li><li><a href="http://la-press.com/article.php?article_id=1730">Bevacizumab: Review of Development, pharmacology, and Application to Brain Tumors<br /><br /></a></li><li><a href="http://la-press.com/article.php?article_id=1734">Using the Multiple Analysis Approach to Reconstruct Phylogenetic Relationships among Planktonic Foraminifera from Highly Divergent and Length-polymorphic SSU rDNA Sequences</a></li></ul><span style="font-weight: bold;">Week 45 (2-8 November)</span><br /><ul><li><a href="http://www.la-press.com/article.php?article_id=1721">Effects of Nebivolol on Endothelial Function and Exercise Parameters in Patients with Slow Coronary Flow</a><br /><br /></li><li><a href="http://www.la-press.com/article.php?article_id=1722">A Review of Topical Imiquimod in the Management of Basal Cell Carcinoma, Actinic Keratoses, and Other Skin Lesions</a></li></ul><div class="blogger-post-footer"><img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7404115720438716495-3789144456468890127?l=libertasacademica.blogspot.com' alt='' /></div><div class="feedflare"> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=4AY-Adz4An0:jdF48_RINA8:yIl2AUoC8zA"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?d=yIl2AUoC8zA" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=4AY-Adz4An0:jdF48_RINA8:63t7Ie-LG7Y"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?d=63t7Ie-LG7Y" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=4AY-Adz4An0:jdF48_RINA8:7Q72WNTAKBA"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?d=7Q72WNTAKBA" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=4AY-Adz4An0:jdF48_RINA8:V_sGLiPBpWU"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?i=4AY-Adz4An0:jdF48_RINA8:V_sGLiPBpWU" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=4AY-Adz4An0:jdF48_RINA8:qj6IDK7rITs"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?d=qj6IDK7rITs" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=4AY-Adz4An0:jdF48_RINA8:TzevzKxY174"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?d=TzevzKxY174" border="0"></img></a> </div><img src="http://feeds.feedburner.com/~r/LibertasAcademica/~4/4AY-Adz4An0" height="1" width="1"/>Tom Hillhttp://www.blogger.com/profile/14499465026739684247tom.hill@la-press.com0http://libertasacademica.blogspot.com/2009/12/open-access-articles-published-in.htmltag:blogger.com,1999:blog-7404115720438716495.post-88761384637046700502009-12-09T16:01:00.002+13:002009-12-09T16:06:56.578+13:002009-12-09T16:06:56.578+13:00Pubmed visibility statistics for November are now available for the following journals:<br /><ul><li style="font-style: italic;"><a href="http://bit.ly/5IQOK0">Analytical Chemistry Insights</a><br /><br /></li><li style="font-style: italic;"><a href="http://bit.ly/5AfXPx">Bioinformatics and Biology Insights</a><br /><br /></li><li style="font-style: italic;"><a href="http://bit.ly/7OfYth">Biomarker Insights</a><br /><br /></li><li style="font-style: italic;"><a href="http://bit.ly/7nxRal">Cancer Informatics</a><br /><br /></li><li style="font-style: italic;"><a href="http://bit.ly/5zUhYw">Evolutionary Bioinformatics</a><br /><br /></li><li style="font-style: italic;"><a href="http://bit.ly/8GyniS">Gene Regulation and Systems Biology</a><br /><a href="http://bit.ly/5e3OVy"><br /></a></li><li><a href="http://bit.ly/5e3OVy"><span style="font-style: italic;">Perspectives in Medicinal Chemistry</span></a><br /></li></ul><div class="blogger-post-footer"><img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7404115720438716495-8876138463704670050?l=libertasacademica.blogspot.com' alt='' /></div><div class="feedflare"> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=LRyDlc7v5Bw:tcslR21syZY:yIl2AUoC8zA"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?d=yIl2AUoC8zA" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=LRyDlc7v5Bw:tcslR21syZY:63t7Ie-LG7Y"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?d=63t7Ie-LG7Y" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=LRyDlc7v5Bw:tcslR21syZY:7Q72WNTAKBA"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?d=7Q72WNTAKBA" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=LRyDlc7v5Bw:tcslR21syZY:V_sGLiPBpWU"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?i=LRyDlc7v5Bw:tcslR21syZY:V_sGLiPBpWU" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=LRyDlc7v5Bw:tcslR21syZY:qj6IDK7rITs"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?d=qj6IDK7rITs" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=LRyDlc7v5Bw:tcslR21syZY:TzevzKxY174"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?d=TzevzKxY174" border="0"></img></a> </div><img src="http://feeds.feedburner.com/~r/LibertasAcademica/~4/LRyDlc7v5Bw" height="1" width="1"/>Tom Hillhttp://www.blogger.com/profile/14499465026739684247tom.hill@la-press.com0http://libertasacademica.blogspot.com/2009/12/november-pubmed-visibility-statistics.htmltag:blogger.com,1999:blog-7404115720438716495.post-39883087336383195162009-12-09T15:39:00.003+13:002009-12-09T15:44:27.543+13:002009-12-09T15:44:27.543+13:00Pubmed visibility statistics for <a href="http://www.la-press.com/perspectives-in-medicinal-chemistry-journal-j25"><span style="font-style: italic;">Perspectives in Medicinal Chemistry</span></a> in November 2009:<br /><br /><div style="text-align: center; font-weight: bold;"><span style="font-size:130%;">Total retrievals in November: 1,313</span><br /></div><br /><br /><span style="font-style: italic;font-size:78%;" >Source: NIH PMC Publisher Services Statistics</span><div class="blogger-post-footer"><img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7404115720438716495-3988308733638319516?l=libertasacademica.blogspot.com' alt='' /></div><div class="feedflare"> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=PydSvTh7JIs:KTM-hmteqHM:yIl2AUoC8zA"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?d=yIl2AUoC8zA" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=PydSvTh7JIs:KTM-hmteqHM:63t7Ie-LG7Y"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?d=63t7Ie-LG7Y" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=PydSvTh7JIs:KTM-hmteqHM:7Q72WNTAKBA"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?d=7Q72WNTAKBA" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=PydSvTh7JIs:KTM-hmteqHM:V_sGLiPBpWU"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?i=PydSvTh7JIs:KTM-hmteqHM:V_sGLiPBpWU" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=PydSvTh7JIs:KTM-hmteqHM:qj6IDK7rITs"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?d=qj6IDK7rITs" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=PydSvTh7JIs:KTM-hmteqHM:TzevzKxY174"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?d=TzevzKxY174" border="0"></img></a> </div><img src="http://feeds.feedburner.com/~r/LibertasAcademica/~4/PydSvTh7JIs" height="1" width="1"/>Tom Hillhttp://www.blogger.com/profile/14499465026739684247tom.hill@la-press.com0http://libertasacademica.blogspot.com/2009/12/perspectives-in-medicinal-chemistry.htmltag:blogger.com,1999:blog-7404115720438716495.post-73508080809132804242009-12-09T15:34:00.003+13:002009-12-09T15:44:24.902+13:002009-12-09T15:44:24.902+13:00Pubmed visibility statistics for <a href="http://www.la-press.com/gene-regulation-and-systems-biology-journal-j26"><span style="font-style: italic;">Gene Regulation and Systems Biology</span></a> in November 2009:<br /><br /><div style="text-align: center; font-weight: bold;"><span style="font-size:130%;">Total retrievals for November: 1,406</span><br /><br /><div style="text-align: left;"><span style="font-style: italic;font-size:78%;" ><span style="font-weight: normal;"><br />Source: NIH PMC Publisher Services Statistics</span></span><br /></div></div><div class="blogger-post-footer"><img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7404115720438716495-7350808080913280424?l=libertasacademica.blogspot.com' alt='' /></div><div class="feedflare"> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=vOGvZms-vtI:WQRwGEdjKYM:yIl2AUoC8zA"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?d=yIl2AUoC8zA" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=vOGvZms-vtI:WQRwGEdjKYM:63t7Ie-LG7Y"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?d=63t7Ie-LG7Y" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=vOGvZms-vtI:WQRwGEdjKYM:7Q72WNTAKBA"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?d=7Q72WNTAKBA" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=vOGvZms-vtI:WQRwGEdjKYM:V_sGLiPBpWU"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?i=vOGvZms-vtI:WQRwGEdjKYM:V_sGLiPBpWU" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=vOGvZms-vtI:WQRwGEdjKYM:qj6IDK7rITs"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?d=qj6IDK7rITs" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=vOGvZms-vtI:WQRwGEdjKYM:TzevzKxY174"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?d=TzevzKxY174" border="0"></img></a> </div><img src="http://feeds.feedburner.com/~r/LibertasAcademica/~4/vOGvZms-vtI" height="1" width="1"/>Tom Hillhttp://www.blogger.com/profile/14499465026739684247tom.hill@la-press.com0http://libertasacademica.blogspot.com/2009/12/gene-regulation-and-systems-biology.htmltag:blogger.com,1999:blog-7404115720438716495.post-10416010700987435712009-12-09T15:29:00.002+13:002009-12-09T15:34:23.956+13:002009-12-09T15:34:23.956+13:00Pubmed visibility statistics for <a href="http://www.la-press.com/cancer-informatics-journal-j10"><span style="font-style: italic;">Cancer Informatics</span></a> in November 2009:<br /><br /><div style="text-align: center; font-weight: bold;"><span style="font-size:130%;">Total retrievals in November: 5,847</span><br /><br /><div style="text-align: left;"><br /><span style="font-style: italic; font-weight: normal;"><span style="font-size:78%;">Source: NIH PMC Publisher Services Statistics</span></span><br /></div></div><div class="blogger-post-footer"><img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7404115720438716495-1041601070098743571?l=libertasacademica.blogspot.com' alt='' /></div><div class="feedflare"> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=xCek_THoNWQ:VGnBEOONXl0:yIl2AUoC8zA"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?d=yIl2AUoC8zA" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=xCek_THoNWQ:VGnBEOONXl0:63t7Ie-LG7Y"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?d=63t7Ie-LG7Y" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=xCek_THoNWQ:VGnBEOONXl0:7Q72WNTAKBA"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?d=7Q72WNTAKBA" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=xCek_THoNWQ:VGnBEOONXl0:V_sGLiPBpWU"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?i=xCek_THoNWQ:VGnBEOONXl0:V_sGLiPBpWU" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=xCek_THoNWQ:VGnBEOONXl0:qj6IDK7rITs"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?d=qj6IDK7rITs" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=xCek_THoNWQ:VGnBEOONXl0:TzevzKxY174"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?d=TzevzKxY174" border="0"></img></a> </div><img src="http://feeds.feedburner.com/~r/LibertasAcademica/~4/xCek_THoNWQ" height="1" width="1"/>Tom Hillhttp://www.blogger.com/profile/14499465026739684247tom.hill@la-press.com0http://libertasacademica.blogspot.com/2009/12/cancer-informatics-pubmed-visibility.htmltag:blogger.com,1999:blog-7404115720438716495.post-44434530095563163632009-12-09T15:26:00.000+13:002009-12-09T15:28:48.131+13:002009-12-09T15:28:48.131+13:00<div class="post-body entry-content"> Pubmed visibility statistics for <span style="font-style: italic;"><a href="http://www.la-press.com/biomarker-insights-journal-j4">Biomarker Insights</a> </span>in November 2009:<br /><br /><div style="text-align: center; font-weight: bold;"><span style="font-size: 130%;">Total retrievals in November: 5,021</span><br /><br /><div style="text-align: left;"><span style="font-size: 78%;"><br /></span><span style="font-size:78%;"><span style="font-size: 78%;"><span style="font-style: italic;"><span style="font-weight: normal;">Source</span></span>: </span><span style="font-weight: normal; font-size: 78%;"><span style="font-style: italic;">NIH PMC Publisher Services Statistics</span></span></span></div></div> </div> <script charset="utf-8" src="http://feeds.feedburner.com/%7Es/LibertasAcademica?i=http://libertasacademica.blogspot.com/2009/12/analytical-chemistry-insights-pubmed.html" type="text/javascript"></script><script src="http://feeds.feedburner.com/%7Es/LibertasAcademica?i=http%3A//libertasacademica.blogspot.com/2009/12/analytical-chemistry-insights-pubmed.html&amp;showad=true" type="text/javascript"></script> <span class="post-author vcard"> </span><div class="blogger-post-footer"><img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7404115720438716495-4443453009556316363?l=libertasacademica.blogspot.com' alt='' /></div><div class="feedflare"> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=STFv7gbRHq8:jHo60xNeq8E:yIl2AUoC8zA"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?d=yIl2AUoC8zA" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=STFv7gbRHq8:jHo60xNeq8E:63t7Ie-LG7Y"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?d=63t7Ie-LG7Y" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=STFv7gbRHq8:jHo60xNeq8E:7Q72WNTAKBA"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?d=7Q72WNTAKBA" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=STFv7gbRHq8:jHo60xNeq8E:V_sGLiPBpWU"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?i=STFv7gbRHq8:jHo60xNeq8E:V_sGLiPBpWU" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=STFv7gbRHq8:jHo60xNeq8E:qj6IDK7rITs"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?d=qj6IDK7rITs" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=STFv7gbRHq8:jHo60xNeq8E:TzevzKxY174"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?d=TzevzKxY174" border="0"></img></a> </div><img src="http://feeds.feedburner.com/~r/LibertasAcademica/~4/STFv7gbRHq8" height="1" width="1"/>Tom Hillhttp://www.blogger.com/profile/14499465026739684247tom.hill@la-press.com0http://libertasacademica.blogspot.com/2009/12/biomarker-insights-pubmed-visibility.htmltag:blogger.com,1999:blog-7404115720438716495.post-2462425124381603002009-12-09T15:24:00.003+13:002009-12-09T15:29:34.172+13:002009-12-09T15:29:34.172+13:00Pubmed visibility statistics for <a href="http://www.la-press.com/bioinformatics-and-biology-insights-journal-j39"><span style="text-decoration: underline;"><span style="font-style: italic;">Bioinformatics and Biology Insights</span></span></a><span style="font-style: italic;"><a href="http://www.la-press.com/analytical-chemistry-insights-journal-j1"></a> </span>in November 2009:<br /><br /><div style="text-align: center; font-weight: bold;"><span style="font-size:130%;">Total retrievals in November: 1,572</span><br /><br /><div style="text-align: left;"><span style="font-size:78%;"><span style="font-size:78%;"><br /></span><span style="font-size:78%;"><span style="font-style: italic;"><span style="font-weight: normal;">Source</span></span>: </span></span><span style="font-weight: normal;font-size:78%;" ><span style="font-style: italic;"><span style="font-size:78%;">NIH PMC Publisher Services Statistics</span><br /><br /></span></span></div></div><div class="blogger-post-footer"><img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7404115720438716495-246242512438160300?l=libertasacademica.blogspot.com' alt='' /></div><div class="feedflare"> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=GPNAVILQV0U:LvrKlLPiAn8:yIl2AUoC8zA"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?d=yIl2AUoC8zA" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=GPNAVILQV0U:LvrKlLPiAn8:63t7Ie-LG7Y"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?d=63t7Ie-LG7Y" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=GPNAVILQV0U:LvrKlLPiAn8:7Q72WNTAKBA"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?d=7Q72WNTAKBA" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=GPNAVILQV0U:LvrKlLPiAn8:V_sGLiPBpWU"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?i=GPNAVILQV0U:LvrKlLPiAn8:V_sGLiPBpWU" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=GPNAVILQV0U:LvrKlLPiAn8:qj6IDK7rITs"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?d=qj6IDK7rITs" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=GPNAVILQV0U:LvrKlLPiAn8:TzevzKxY174"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?d=TzevzKxY174" border="0"></img></a> </div><img src="http://feeds.feedburner.com/~r/LibertasAcademica/~4/GPNAVILQV0U" height="1" width="1"/>Tom Hillhttp://www.blogger.com/profile/14499465026739684247tom.hill@la-press.com0http://libertasacademica.blogspot.com/2009/12/bioinformatics-and-biology-insights.htmltag:blogger.com,1999:blog-7404115720438716495.post-743984749121228922009-12-09T15:14:00.003+13:002009-12-09T15:23:32.537+13:002009-12-09T15:23:32.537+13:00Pubmed visibility statistics for <span style="font-style: italic;"><a href="http://www.la-press.com/analytical-chemistry-insights-journal-j1">Analytical Chemistry Insights</a> </span>in November 2009:<br /><br /><div style="text-align: center; font-weight: bold;"><span style="font-size:130%;">Total retrievals in November: 2,350</span><br /><br /><div style="text-align: left;"><span style="font-size:78%;"><br /></span><span style="font-size:78%;"><span style="font-style: italic;"><span style="font-weight: normal;">Source</span></span>: </span><span style="font-weight: normal;font-size:78%;" ><span style="font-style: italic;">NIH PMC Publisher Services Statistics</span></span></div></div><div class="blogger-post-footer"><img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7404115720438716495-74398474912122892?l=libertasacademica.blogspot.com' alt='' /></div><div class="feedflare"> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=DAHIGSxpwpc:abROcg0mkmc:yIl2AUoC8zA"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?d=yIl2AUoC8zA" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=DAHIGSxpwpc:abROcg0mkmc:63t7Ie-LG7Y"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?d=63t7Ie-LG7Y" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=DAHIGSxpwpc:abROcg0mkmc:7Q72WNTAKBA"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?d=7Q72WNTAKBA" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=DAHIGSxpwpc:abROcg0mkmc:V_sGLiPBpWU"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?i=DAHIGSxpwpc:abROcg0mkmc:V_sGLiPBpWU" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=DAHIGSxpwpc:abROcg0mkmc:qj6IDK7rITs"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?d=qj6IDK7rITs" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=DAHIGSxpwpc:abROcg0mkmc:TzevzKxY174"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?d=TzevzKxY174" border="0"></img></a> </div><img src="http://feeds.feedburner.com/~r/LibertasAcademica/~4/DAHIGSxpwpc" height="1" width="1"/>Tom Hillhttp://www.blogger.com/profile/14499465026739684247tom.hill@la-press.com0http://libertasacademica.blogspot.com/2009/12/analytical-chemistry-insights-pubmed.htmltag:blogger.com,1999:blog-7404115720438716495.post-88790550207194997972009-12-09T15:06:00.006+13:002009-12-09T15:23:42.440+13:002009-12-09T15:23:42.440+13:00Pubmed visibility statistics for <span style="font-style: italic;"><a href="http://www.la-press.com/evolutionary-bioinformatics-journal-j17">Evolutionary Bioinformatics</a> </span>in November 2009:<br /><br /><div style="text-align: center;"><span style="font-weight: bold;font-size:130%;" >Total retrievals in November: 3,575</span><br /><br /><div style="text-align: left;"><span style="font-size:78%;"><span style="font-style: italic;"><br />Source: NIH PMC Publisher Services Statistics</span></span><br /></div><br /><br /></div><div class="blogger-post-footer"><img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7404115720438716495-8879055020719499797?l=libertasacademica.blogspot.com' alt='' /></div><div class="feedflare"> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=8WZQkfEN6vU:TVsLAbPFB5k:yIl2AUoC8zA"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?d=yIl2AUoC8zA" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=8WZQkfEN6vU:TVsLAbPFB5k:63t7Ie-LG7Y"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?d=63t7Ie-LG7Y" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=8WZQkfEN6vU:TVsLAbPFB5k:7Q72WNTAKBA"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?d=7Q72WNTAKBA" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=8WZQkfEN6vU:TVsLAbPFB5k:V_sGLiPBpWU"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?i=8WZQkfEN6vU:TVsLAbPFB5k:V_sGLiPBpWU" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=8WZQkfEN6vU:TVsLAbPFB5k:qj6IDK7rITs"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?d=qj6IDK7rITs" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=8WZQkfEN6vU:TVsLAbPFB5k:TzevzKxY174"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?d=TzevzKxY174" border="0"></img></a> </div><img src="http://feeds.feedburner.com/~r/LibertasAcademica/~4/8WZQkfEN6vU" height="1" width="1"/>Tom Hillhttp://www.blogger.com/profile/14499465026739684247tom.hill@la-press.com0http://libertasacademica.blogspot.com/2009/12/evolutionary-bioinformatics-pubmed.htmltag:blogger.com,1999:blog-7404115720438716495.post-4127305776654232582009-12-07T17:02:00.004+13:002009-12-07T17:12:15.610+13:002009-12-07T17:12:15.610+13:00In 2010 many of our open access journals will be publishing special issues on topics of importance.<br /><br /><span style="font-weight: bold;">Read more about the special issues</span><br /><ul style="font-style: italic;"><li><a href="http://libertasacademica.blogspot.com/2009/12/proposals-invited-for-air-soil-and.html">Air, Soil and Water Research</a><br /><br /></li><li><a href="http://libertasacademica.blogspot.com/2009/12/proposals-invited-for-bioinformatics.html">Bioinformatics and Biology Insights</a><br /><a href="http://libertasacademica.blogspot.com/2009/12/proposals-invited-for-biochemistry.html"><br /></a></li><li><a href="http://libertasacademica.blogspot.com/2009/12/proposals-invited-for-biochemistry.html">Biochemistry Insights</a><br /><br /></li><li><a href="http://libertasacademica.blogspot.com/2009/12/proposals-invited-for-breast-cancer.html">Breast Cancer: Basic and Clinical Research</a><br /><a href="http://libertasacademica.blogspot.com/2009/12/proposals-invited-for-bone-and-tissue.html"><br /></a></li><li><a href="http://libertasacademica.blogspot.com/2009/12/proposals-invited-for-bone-and-tissue.html">Bone and Tissue Regeneration Insights</a><br /><br /></li><li><a href="http://libertasacademica.blogspot.com/2009/12/proposals-invited-for-cell-and-tissue.html">Cell and Tissue Transplantation Insights</a><br /><br /></li><li><a href="http://libertasacademica.blogspot.com/2009/12/proposals-invited-for-clinical-medicine.html">Clinical Medicine: Oncology</a><br /><br /></li><li><a href="http://libertasacademica.blogspot.com/2009/12/proposals-invited-for-clinical-medicine_03.html">Clinical Medicine: Reproductive Health</a><br /><br /></li><li><a href="http://libertasacademica.blogspot.com/2009/12/proposals-invited-for-environmental.html">Environmental Health Insights</a><br /><br /></li><li><a href="http://libertasacademica.blogspot.com/2009/12/proposals-invited-for-genetics-and.html">Genetic and Epigenetics</a><br /><br /></li><li><a href="http://libertasacademica.blogspot.com/2009/12/proposals-invited-for-genomics-insights.html">Genomics Insights</a><br /><a href="http://libertasacademica.blogspot.com/2009/12/proposals-invited-for-healthy-aging-and.html"><br /></a></li><li><a href="http://libertasacademica.blogspot.com/2009/12/proposals-invited-for-healthy-aging-and.html">Healthy Aging and Clinical Care in the Elderly</a><br /><br /></li><li><a href="http://libertasacademica.blogspot.com/2009/12/proposals-invited-for-human-parasitic.html">Human Parasitic Diseases</a><br /><br /></li><li><a href="http://libertasacademica.blogspot.com/2009/12/proposals-invited-for-immunotherapy.html">Immunotherapy Insights</a><br /><br /></li><li><a href="http://libertasacademica.blogspot.com/2009/12/proposals-invited-for-palliative-care.html">Palliative Care: Research and Treatment</a><br /><br /></li><li><a href="http://libertasacademica.blogspot.com/2009/12/proposals-invited-for-perspectives-in.html">Perspectives in Medicinal Chemistry</a><br /><br /></li><li><a href="http://libertasacademica.blogspot.com/2009/12/proposals-invited-for-primary.html">Primary Prevention Insights</a><br /><br /></li><li><a href="http://libertasacademica.blogspot.com/2009/12/proposals-invited-for-rehabilitation.html">Rehabilitation Process and Outcome</a><br /><br /></li><li><a href="http://libertasacademica.blogspot.com/2009/12/proposals-invited-for-signal.html">Signal Transduction Insights</a><br /><a href="http://libertasacademica.blogspot.com/2009/12/proposals-invited-for-translational.html"><br /></a></li><li><a href="http://libertasacademica.blogspot.com/2009/12/proposals-invited-for-translational.html">Translational Oncogenomics</a></li></ul><div class="blogger-post-footer"><img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7404115720438716495-412730577665423258?l=libertasacademica.blogspot.com' alt='' /></div><div class="feedflare"> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=c09ilu60FxA:v32afjIw5hI:yIl2AUoC8zA"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?d=yIl2AUoC8zA" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=c09ilu60FxA:v32afjIw5hI:63t7Ie-LG7Y"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?d=63t7Ie-LG7Y" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=c09ilu60FxA:v32afjIw5hI:7Q72WNTAKBA"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?d=7Q72WNTAKBA" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=c09ilu60FxA:v32afjIw5hI:V_sGLiPBpWU"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?i=c09ilu60FxA:v32afjIw5hI:V_sGLiPBpWU" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=c09ilu60FxA:v32afjIw5hI:qj6IDK7rITs"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?d=qj6IDK7rITs" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=c09ilu60FxA:v32afjIw5hI:TzevzKxY174"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?d=TzevzKxY174" border="0"></img></a> </div><img src="http://feeds.feedburner.com/~r/LibertasAcademica/~4/c09ilu60FxA" height="1" width="1"/>Tom Hillhttp://www.blogger.com/profile/14499465026739684247tom.hill@la-press.com0http://libertasacademica.blogspot.com/2009/12/2010-special-issues.htmltag:blogger.com,1999:blog-7404115720438716495.post-80500828478617264912009-12-07T16:56:00.002+13:002009-12-07T17:01:12.308+13:002009-12-07T17:01:12.308+13:00Dear colleagues,<br /><br />I invite you to submit a paper to the forthcoming special issue of <span style="font-style: italic;">Translational Oncogenomics</span>.<br /><br /><span style="font-weight: bold;">About the special issue</span><br /><br />This special issue is titled "Transcriptomes and Epigenomes in Cancer".<br /><br />The aim of this special issue is to provide a forum for timely primary articles and reviews on genome wide transcriptional and epigenetic regulation during cancer progression and response to therapy.<br /><br />Papers within the scope of this special issue include:<br /><ul><li>Gene expression profiling, including microarray and deep-sequencing studies related to cancer initiation, progression, diagnosis and response to therapy.<br /><br /></li><li>Genome wide transcription factor binding of oncogenes and tumor suppressor genes.<br /><br /></li><li>Epigenetic regulation of the chromatin landscape in cancer.<br /><br /></li><li>Large-scale DNA methylation analysis.<br /><br /></li><li>miRNA profiling.<br /><br /></li><li>Review articles in the area of transcriptomics and epigenomics focused on tumor type and/or response to a class of therapeutics. Examples: the transcriptome of cancer stem cells, gene profiles associated with metastasis, tumor response to cytotoxic or targeted therapies.<br /><br /></li><li>Original papers or review articles on bioinformatic, statistical and computational methods that support genome-wide studies. <br /><br /></li><li>Commentaries and perspectives related to Transcriptomes and Epigenomes in Cancer.</li></ul><span style="font-weight: bold;">Deadlines</span><br /><br />Registration of manuscripts: 1 May 2010<br /><br />Manuscripts submitted: 1 June 2010<br /><br />Completion of peer review: circa 1 July 2010<br /><br />Resubmission of revised manuscripts: circa 1 September 2010<br /><br /><span style="font-weight: bold;">How to participate</span><br /><br /><a href="https://www.formspring.com/forms/?764065-N8b5qIMO2O">To register your manuscript visit this page</a>. All manuscripts are subject to approval by the Editor in Chief.<br /><br /><span style="font-weight: bold;">Article processing fees</span><br /><br />Submissions are welcomed from individuals not on the editorial board. An article processing fee will be charged in recognition of the journal’s open access status.<br /><br />Editorial board members are encouraged to make use of the special benefits available to them.<br /><br /><span style="font-weight: bold;">General call for papers</span><br /><br />A <a href="http://www.la-press.com/announcements-translational-oncogenomics-call-for-papers">general call for papers</a> was recently announced. I continue to welcome submissions to the general volume. Manuscripts may be submitted at any time.<br /><br /><br />Your sincerely,<br /><br />Michael Spinella,<br />Editor in Chief<br /><span style="font-style: italic;">Translational Oncogenomics</span><div class="blogger-post-footer"><img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7404115720438716495-8050082847861726491?l=libertasacademica.blogspot.com' alt='' /></div><div class="feedflare"> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=bg7n0ORuh3s:FMDsdxLBo2M:yIl2AUoC8zA"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?d=yIl2AUoC8zA" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=bg7n0ORuh3s:FMDsdxLBo2M:63t7Ie-LG7Y"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?d=63t7Ie-LG7Y" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=bg7n0ORuh3s:FMDsdxLBo2M:7Q72WNTAKBA"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?d=7Q72WNTAKBA" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=bg7n0ORuh3s:FMDsdxLBo2M:V_sGLiPBpWU"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?i=bg7n0ORuh3s:FMDsdxLBo2M:V_sGLiPBpWU" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=bg7n0ORuh3s:FMDsdxLBo2M:qj6IDK7rITs"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?d=qj6IDK7rITs" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=bg7n0ORuh3s:FMDsdxLBo2M:TzevzKxY174"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?d=TzevzKxY174" border="0"></img></a> </div><img src="http://feeds.feedburner.com/~r/LibertasAcademica/~4/bg7n0ORuh3s" height="1" width="1"/>Tom Hillhttp://www.blogger.com/profile/14499465026739684247tom.hill@la-press.com0http://libertasacademica.blogspot.com/2009/12/proposals-invited-for-translational.htmltag:blogger.com,1999:blog-7404115720438716495.post-44622200338717995672009-12-07T16:08:00.001+13:002009-12-07T16:13:07.597+13:002009-12-07T16:13:07.597+13:00Dear colleagues,<br /><br />On behalf of the Editorial Board and publisher, it is my pleasure to cordially invite you to contribute your work to Signal Transduction in Cell Growth and Division, the forthcoming special issue of <span style="font-style: italic;">Signal Transduction Insights</span>.<br /><br /><span style="font-weight: bold;">About the special issue</span><br /><br />We welcome high-quality research on all aspects of normal and abnormal signal transduction involved in cell growth, cell cycle and cell division. Of interest are all signaling components and mechanisms that control and coordinate the above-mentioned processes. This includes, but is not limited to, research aimed at further understanding signaling events related to stem cells, embryonic development as well as aberrations in signaling pathways relevant to cancer and other diseases. The special issue integrates research from various areas of biology and its applications in health and will be of greatest possible benefit to the scientific and clinical communities.<br /><br /><span style="font-weight: bold;">About the journal</span><br /><br /><span style="font-style: italic;">Signal Transduction Insights</span> is an open access, peer reviewed online journal that covers all aspects of signal transduction in cells, from molecular and intracellular to intercellular levels. We welcome high-quality research in the area of normal and abnormal signal transduction. This includes, but is not limited to, signaling systems involved in cell communication, cell growth and cell cycle control, cell differentiation, cellular senescence, cell death as well as relevant mechanisms controlling gene expression. Included is also research on signaling events related to functions of stem cells, carcinogenesis and cancerous stem cells. Of significant interest is research aimed at further understanding disease-related aberrations in signaling pathways and the fast-growing area of signal transduction therapy. The journal integrates research from various areas of biology and its applications in health.<br /><br /><span style="font-weight: bold;">Deadlines</span><br /><br />Registration of manuscripts: 1 May 2010<br /><br />Manuscripts submitted: 1 June 2010<br /><br />Completion of peer review: circa 1 July 2010<br /><br />Resubmission of revised manuscripts: circa 1 September 2010<br /><br /><span style="font-weight: bold;">How to participate</span><br /><br /><a href="https://www.formspring.com/forms/?764065-N8b5qIMO2O">To register your manuscript visit this page</a>. All manuscripts are subject to approval by the Editor in Chief.<br /><br /><span style="font-weight: bold;">Article processing fees</span><br /><br />Submissions are welcomed from individuals not on the editorial board. An article processing fee will be charged in recognition of the journal’s open access status.<br /><br />Editorial board members are encouraged to use their APF waiver or discount.<br /><br /><span style="font-weight: bold;">General call for papers</span><br /><br />A <a href="http://www.la-press.com/announcements-signal-transduction-insights-call-for-papers">general call for papers</a> was recently announced. I continue to welcome submissions to the general volume. Manuscripts may be submitted at any time.<br /><br />Your sincerely,<br /><br />Dr. Edgar Grinstein<br />Editor-in-Chief<br /><span style="font-style: italic;">Signal Transduction Insights</span><div class="blogger-post-footer"><img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7404115720438716495-4462220033871799567?l=libertasacademica.blogspot.com' alt='' /></div><div class="feedflare"> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=hotKM2HqYoQ:xzHd1gE17rg:yIl2AUoC8zA"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?d=yIl2AUoC8zA" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=hotKM2HqYoQ:xzHd1gE17rg:63t7Ie-LG7Y"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?d=63t7Ie-LG7Y" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=hotKM2HqYoQ:xzHd1gE17rg:7Q72WNTAKBA"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?d=7Q72WNTAKBA" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=hotKM2HqYoQ:xzHd1gE17rg:V_sGLiPBpWU"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?i=hotKM2HqYoQ:xzHd1gE17rg:V_sGLiPBpWU" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=hotKM2HqYoQ:xzHd1gE17rg:qj6IDK7rITs"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?d=qj6IDK7rITs" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=hotKM2HqYoQ:xzHd1gE17rg:TzevzKxY174"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?d=TzevzKxY174" border="0"></img></a> </div><img src="http://feeds.feedburner.com/~r/LibertasAcademica/~4/hotKM2HqYoQ" height="1" width="1"/>Tom Hillhttp://www.blogger.com/profile/14499465026739684247tom.hill@la-press.com0http://libertasacademica.blogspot.com/2009/12/proposals-invited-for-signal.htmltag:blogger.com,1999:blog-7404115720438716495.post-20938245708198845362009-12-07T16:03:00.001+13:002009-12-07T16:06:04.936+13:002009-12-07T16:06:04.936+13:00Dear colleagues,<br /><br />I invite you to submit a paper to the forthcoming special issue ‘Health Promotion for People with Disabilities’ of <span style="font-style: italic;">Rehabilitation Process and Outcome</span>.<br /><br /><span style="font-weight: bold;">About the special issue</span><br /><br />The aim of this special issue is to examine the role that habilitation and rehabilitation professionals have in advancing the health of individuals with disabilities. Traditionally, this has been relegated to primary care but increasingly rehabilitation providers have become aware that reducing health risks and promoting opportunities for healthy living is a key task alongside the restoration or maintenance of function. It is also a case of providing equitable access to preventive health care, including health risk behavior counselling, screenings, health checks and immunizations.<br /><br />As a group, people with disabilities may not have overall poorer health but due to a variety and complexity of factors, including greater susceptibility, delayed access to preventive services they may be at greater risk for particular conditions including cancer, cardiovascular disease, diabetes, or osteoporosis.<br /><br />For example, there is mounting evidence that people with spinal cord injuries are at a higher risk for developing bladder cancer or cardiovascular disease. These are preventable or treatable secondary conditions.<br /><br />Data from the US National Health Interview Survey (NHIS) has shown that people with activity limitations are more likely to report health risk behaviors including smoking, alcohol consumption and physical inactivity than people without.<br /><br />This special issue will feature examples of health education and promotion initiatives that target people with disabilities. Of particular interest are intervention studies, manuscripts that address outcome assessment, theoretical and conceptual developments, clinical and community-based studies. Moreover, we are calling for papers that examine the rehabilitative context of health promotion, i.e. community-based interventions to promote healthy lifestyles for people with disabilities. This also includes an examination of environmental, social and individual barriers and facilitators of access to health promotion initiatives.<br /><br />Examples of health promotion issues include weight self-management, physical activity and exercise, smoking cessation, reduction of alcohol consumption but also innovative use of technology to provide people with opportunities to access and utilize health risk behavior counselling, cancer screenings and self management support.<br /><br />The special issue hopes to feature examples from a wide variety of disability populations, including those involving people with physical, sensory, developmental, intellectual and mental health impairments.<br /><br />Health promotion in the context of rehabilitation positions rehabilitation professionals at the intersection of public health, clinical practice and self-management support.<br /><br /><span style="font-weight: bold;">Deadlines</span><br /><br />Registration of manuscripts: 1 May 2010<br /><br />Manuscripts submitted: 1 June 2010<br /><br />Completion of peer review: circa 1 July 2010<br /><br />Resubmission of revised manuscripts: circa 1 September 2010<br /><br /><span style="font-weight: bold;">How to participate</span><br /><br /><a href="https://www.formspring.com/forms/?764065-N8b5qIMO2O">To register your manuscript visit this page</a>. All manuscripts are subject to approval by the Editor in Chief.<br /><br /><span style="font-weight: bold;">Article processing fees</span><br /><br />Submissions are welcomed from individuals not on the editorial board. An article processing fee will be charged in recognition of the journal’s open access status.<br /><br />Editorial board members are encouraged to use their APF waiver or discount.<br /><br /><span style="font-weight: bold;">General call for papers</span><br /><br />A <a href="http://www.la-press.com/announcements-rehabilitation-process-and-outcome-call-for-papers">general call for papers</a> was recently announced. I continue to welcome submissions to the general volume. Manuscripts may be submitted at any time.<br /><br /><br />Your sincerely,<br /><br />Thilo Kroll, PhD<br />Editor in Chief<br /><span style="font-style: italic;">Rehabilitation Process and Outcome</span><div class="blogger-post-footer"><img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7404115720438716495-2093824570819884536?l=libertasacademica.blogspot.com' alt='' /></div><div class="feedflare"> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=hfyRELeMzv8:OB7XdulIQHc:yIl2AUoC8zA"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?d=yIl2AUoC8zA" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=hfyRELeMzv8:OB7XdulIQHc:63t7Ie-LG7Y"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?d=63t7Ie-LG7Y" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=hfyRELeMzv8:OB7XdulIQHc:7Q72WNTAKBA"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?d=7Q72WNTAKBA" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=hfyRELeMzv8:OB7XdulIQHc:V_sGLiPBpWU"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?i=hfyRELeMzv8:OB7XdulIQHc:V_sGLiPBpWU" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=hfyRELeMzv8:OB7XdulIQHc:qj6IDK7rITs"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?d=qj6IDK7rITs" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=hfyRELeMzv8:OB7XdulIQHc:TzevzKxY174"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?d=TzevzKxY174" border="0"></img></a> </div><img src="http://feeds.feedburner.com/~r/LibertasAcademica/~4/hfyRELeMzv8" height="1" width="1"/>Tom Hillhttp://www.blogger.com/profile/14499465026739684247tom.hill@la-press.com0http://libertasacademica.blogspot.com/2009/12/proposals-invited-for-rehabilitation.htmltag:blogger.com,1999:blog-7404115720438716495.post-36771547057333030262009-12-07T16:00:00.002+13:002009-12-07T16:02:39.869+13:002009-12-07T16:02:39.869+13:00Dear colleagues,<br /><br />I invite you to submit a paper to the forthcoming special issue of <span style="font-style: italic;">Primary Prevention Insights</span> dedicated to Primary Prevention in Obesity and Comorbidities.<br /><br /><span style="font-weight: bold;">About the special issue<br /></span><br />The prevalence of obesity has increased dramatically over the past 30 years across virtually all populations and age groups. Over 60 percent of adult Americans are now either overweight or obese, and one in six U.S. children and adolescents are overweight. Obesity is a chronic metabolic condition with important public health implications. It is associated with a high risk of cardiovascular disease, diabetes, stroke, some cancers, depression, and numerous other physical and psychological comorbidities, and higher mortality rates from all causes. In addition, obesity disproportionately affects many minority populations and individuals with lower income and education levels, which contributes to excess disease and mortality rates experienced by these groups. <br /><br />Weight loss interventions are costly, difficult, and often unsuccessful at long-term maintenance of weight loss. In addition, it is unclear whether weight loss in those individuals already obese reduces disease risk to the same level as that observed in those who were never obese. Current estimates of obesity-attributable medical costs in the U.S. approach $100 billion per year, a cost projected to increase as the number of obese individuals in the population increases and as those who are currently obese suffer increased consequences of obesity-related comorbidities. Taken together, all these factors make the prevention of obesity and its comorbidities a public health imperative.<br /><br />Obesity is a complex condition that results from interaction of genetic, behavioral, and environmental factors. Dynamic processes that occur over the life span determine the development of obesity and associated chronic diseases. Perturbations, or “insults,” that determine excessive weight gain leading to obesity may vary across life stages from before conception to embryonic, fetal, infant, childhood, adolescent, and adult life. These insults may include a range of determinants, including societal, lifestyle, biological, and genetic factors, and can act independently or have additive or synergistic effects on the structure or function of organs, tissues, and body systems. <br /><br />We invite authors to present original research articles as well as review articles that present the latest advances in identifying, evaluating, and preventing risk factors for obesity and comorbidities during critical or sensitive periods over the life span or in high-risk populations. is Continuing progress in prospectively determining risk factors for weight gain (or weight regain following weight loss) and obesity that result in complications and in effectively preventing and managing these risk factors is key to addressing the worsening worldwide epidemic of obesity and its adverse health consequences. <span style="font-weight: bold;"><br /></span><br /><span style="font-weight: bold;">Deadlines</span><br /><br />Registration of manuscripts: 1 May 2010<br /><br />Manuscripts submitted: 1 June 2010<br /><br />Completion of peer review: circa 1 July 2010<br /><br />Resubmission of revised manuscripts: circa 1 September 2010<br /><br /><span style="font-weight: bold;">How to participate</span><br /><br /><a href="https://www.formspring.com/forms/?764065-N8b5qIMO2O">To register your manuscript visit this page</a>. All manuscripts are subject to approval by the Editor in Chief.<br /><br /><span style="font-weight: bold;">Article processing fees</span><br /><br />Submissions are welcomed from individuals not on the editorial board. An article processing fee will be charged in recognition of the journal’s open access status.<br /><br />Editorial board members are encouraged to make use of the special benefits available to them.<br /><br /><span style="font-weight: bold;">General call for papers</span><br /><br />A <a href="http://www.la-press.com/announcements-primary-prevention-insights-call-for-papers">general call for papers</a> was recently announced. I continue to welcome submissions to the general volume. Manuscripts may be submitted at any time.<br /><br /><br />Your sincerely,<br /><br />Jun Ma<br />Editor in Chief<br /><span style="font-style: italic;">Primary Prevention Insights</span><div class="blogger-post-footer"><img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7404115720438716495-3677154705733303026?l=libertasacademica.blogspot.com' alt='' /></div><div class="feedflare"> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=b1od3Rg3WqM:zwCw7mXyT8g:yIl2AUoC8zA"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?d=yIl2AUoC8zA" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=b1od3Rg3WqM:zwCw7mXyT8g:63t7Ie-LG7Y"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?d=63t7Ie-LG7Y" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=b1od3Rg3WqM:zwCw7mXyT8g:7Q72WNTAKBA"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?d=7Q72WNTAKBA" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=b1od3Rg3WqM:zwCw7mXyT8g:V_sGLiPBpWU"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?i=b1od3Rg3WqM:zwCw7mXyT8g:V_sGLiPBpWU" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=b1od3Rg3WqM:zwCw7mXyT8g:qj6IDK7rITs"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?d=qj6IDK7rITs" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=b1od3Rg3WqM:zwCw7mXyT8g:TzevzKxY174"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?d=TzevzKxY174" border="0"></img></a> </div><img src="http://feeds.feedburner.com/~r/LibertasAcademica/~4/b1od3Rg3WqM" height="1" width="1"/>Tom Hillhttp://www.blogger.com/profile/14499465026739684247tom.hill@la-press.com0http://libertasacademica.blogspot.com/2009/12/proposals-invited-for-primary.htmltag:blogger.com,1999:blog-7404115720438716495.post-15690588622320210372009-12-07T15:55:00.001+13:002009-12-07T15:58:00.840+13:002009-12-07T15:58:00.840+13:00Dear colleagues,<br /><br />I invite you to submit a paper to the forthcoming special issue of <span style="font-style: italic;">Perspectives in Medicinal Chemistry</span> dedicated to biofilms.<br /><br /><span style="font-weight: bold;">About the special issue</span><br /><br />Bacterial biofilms, surface-adsorbed microbial communities, present major challenges to clinicians and medicinal chemists. In particular, their tolerance to common antibiotics is of great concern. While recent advances have shed light on this protected bacterial growth mode, numerous questions remain open. <br /><br />This thematic issue of <span style="font-style: italic;">Perspectives in Medicinal Chemistry</span> aims to address the diverse challenges in biofilm-related research, which include (but are not limited to) the understanding of molecular mechanisms behind biofilm development, quorum sensing and regulation, biofilms and pathogenesis, as well as the synthesis and discovery of molecules capable of impacting biofilm formation and dispersion.<br /><br /><span style="font-weight: bold;">Deadlines</span><br /><br />Registration of manuscripts: 1 May 2010<br /><br />Manuscripts submitted: 1 June 2010<br /><br />Completion of peer review: circa 1 July 2010<br /><br />Resubmission of revised manuscripts: circa 1 September 2010<br /><br /><span style="font-weight: bold;">How to participate</span><br /><br /><a href="https://www.formspring.com/forms/?764065-N8b5qIMO2O">To register your manuscript visit this page</a>. All manuscripts are subject to approval by the Editor in Chief.<br /><br /><span style="font-weight: bold;">Article processing fees</span><br /><br />Submissions are welcomed from individuals not on the editorial board. An article processing fee will be charged in recognition of the journal’s open access status.<br /><br />Editorial board members are encouraged to make use of the special benefits available to them.<br /><br /><span style="font-weight: bold;">General call for papers</span><br /><br />A <a href="http://libertasacademica.blogspot.com/2009/07/call-for-papers-for-perspectives-in.html">general call for papers</a> was recently announced. I continue to welcome submissions to the general volume. Manuscripts may be submitted at any time.<br /><br /><br />Your sincerely,<br /><br />Yitzhak Tor<br />Editor in Chief<br /><span style="font-style: italic;">Perspectives in Medicinal Chemistry</span><div class="blogger-post-footer"><img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7404115720438716495-1569058862232021037?l=libertasacademica.blogspot.com' alt='' /></div><div class="feedflare"> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=Qa4TqJYZ-7w:XF_QWfkPZ54:yIl2AUoC8zA"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?d=yIl2AUoC8zA" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=Qa4TqJYZ-7w:XF_QWfkPZ54:63t7Ie-LG7Y"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?d=63t7Ie-LG7Y" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=Qa4TqJYZ-7w:XF_QWfkPZ54:7Q72WNTAKBA"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?d=7Q72WNTAKBA" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=Qa4TqJYZ-7w:XF_QWfkPZ54:V_sGLiPBpWU"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?i=Qa4TqJYZ-7w:XF_QWfkPZ54:V_sGLiPBpWU" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=Qa4TqJYZ-7w:XF_QWfkPZ54:qj6IDK7rITs"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?d=qj6IDK7rITs" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=Qa4TqJYZ-7w:XF_QWfkPZ54:TzevzKxY174"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?d=TzevzKxY174" border="0"></img></a> </div><img src="http://feeds.feedburner.com/~r/LibertasAcademica/~4/Qa4TqJYZ-7w" height="1" width="1"/>Tom Hillhttp://www.blogger.com/profile/14499465026739684247tom.hill@la-press.com0http://libertasacademica.blogspot.com/2009/12/proposals-invited-for-perspectives-in.htmltag:blogger.com,1999:blog-7404115720438716495.post-80754640084129575952009-12-07T15:50:00.002+13:002009-12-07T15:55:10.763+13:002009-12-07T15:55:10.763+13:00Dear colleagues,<br /><br />I invite you to submit a paper to the forthcoming special issue of <span style="font-style: italic;">Palliative Care: Research and Treatment</span>, which is titled “Models of Delivery” of Palliative Care.<br /><br /><span style="font-weight: bold;">About the special issue</span><br /><br />Palliative care goes beyond the care of the patient’s disease. It involves care of a patient as a person and of those affected by the patient’s disease. The delivery of palliative care can be both rewarding and challenging. The field is in various stages of evolution in different parts of the world. What is feasible in one setting may not be applicable in another The reasons are many- be it cultural issues, availability of medications, regional rules and regulations, etc. Creative “Models of Delivery” have been implemented in order to deliver the care with the resources available in different settings.<br /><br />I invite all our palliative care colleagues from its various realms to share and educate us of the various models that have evolved. While some have proven to be effective others experiences may have been less fruitful. This is an opportunity to learn from our achievements and disappointments. I look forward to your submissions.<br /><br /><span style="font-weight: bold;">Deadlines</span><br /><br />Registration of manuscripts: 1 May 2010<br /><br />Manuscripts submitted: 1 June 2010<br /><br />Completion of peer review: circa 1 July 2010<br /><br />Resubmission of revised manuscripts: circa 1 September 2010<br /><br /><span style="font-weight: bold;">How to participate</span><br /><br /><a href="https://www.formspring.com/forms/?764065-N8b5qIMO2O">To register your manuscript visit this page</a>. All manuscripts are subject to approval by the Editor in Chief.<br /><br /><span style="font-weight: bold;">Article processing fees</span><br /><br />Submissions are welcomed from individuals not on the editorial board. An article processing fee will be charged in recognition of the journal’s open access status.<br /><br />Editorial board members are encouraged to make use of the special benefits available to them.<br /><br /><span style="font-weight: bold;">General call for papers</span><br /><br />A <a href="http://www.la-press.com/announcements-palliative-care-research-and-treatment-call-for-papers">general call for papers</a> was recently announced. I continue to welcome submissions to the general volume. Manuscripts may be submitted at any time.<br /><br /><br />Your sincerely,<br /><br />Dr Parag Bharadwaj,<br />Editor in Chief<br /><span style="font-style: italic;">Palliative Care: Research and Treatment</span><div class="blogger-post-footer"><img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7404115720438716495-8075464008412957595?l=libertasacademica.blogspot.com' alt='' /></div><div class="feedflare"> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=ShMWunp4_Sw:yBZnzwoLbRg:yIl2AUoC8zA"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?d=yIl2AUoC8zA" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=ShMWunp4_Sw:yBZnzwoLbRg:63t7Ie-LG7Y"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?d=63t7Ie-LG7Y" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=ShMWunp4_Sw:yBZnzwoLbRg:7Q72WNTAKBA"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?d=7Q72WNTAKBA" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=ShMWunp4_Sw:yBZnzwoLbRg:V_sGLiPBpWU"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?i=ShMWunp4_Sw:yBZnzwoLbRg:V_sGLiPBpWU" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=ShMWunp4_Sw:yBZnzwoLbRg:qj6IDK7rITs"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?d=qj6IDK7rITs" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=ShMWunp4_Sw:yBZnzwoLbRg:TzevzKxY174"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?d=TzevzKxY174" border="0"></img></a> </div><img src="http://feeds.feedburner.com/~r/LibertasAcademica/~4/ShMWunp4_Sw" height="1" width="1"/>Tom Hillhttp://www.blogger.com/profile/14499465026739684247tom.hill@la-press.com0http://libertasacademica.blogspot.com/2009/12/proposals-invited-for-palliative-care.htmltag:blogger.com,1999:blog-7404115720438716495.post-76706141551093222902009-12-07T15:33:00.003+13:002009-12-07T15:50:25.138+13:002009-12-07T15:50:25.138+13:00Dear colleagues,<br /><br />I invite you to submit original papers and reviews to the forthcoming special issue of <span style="font-style: italic;">Immunotherapy Insights</span> entitled <span style="font-style: italic;">Current developments in adoptive transfer of lymphocytes selected for specific functions to treat infection and malignancy</span>.<br /><br /><span style="font-weight: bold;">About the special issue</span><br /><br />While much has been learned about the efficacy of donor lymphocyte transfusions in controlling viral infection and malignant disease after stem cell transplantation the transfusion of unselected T cells is associated with graft-versus-host disease.<br /><br />To avoid this problem antigen-specific T cells can be selected and expand in vitro for adoptive transfer. Because of the cost and complexity of the technology the use of antigen specific T cells to treat viral reactivation and relapsed leukemias have been limited to a few pioneering studies in stem cell transplant patients. In recent years there has been considerable progress in developing cheaper faster and less complicated techniques for the manufacture of lymphocytes with specific functions for adoptive transfer in the clinic both in allogeneic stem cell transplants and in other settings.<br /><br />In addition attention has focused on the potential of using Natural Killer cells to treat malignant diseases. It is timely therefore to present these advances in a special issue of Immunotherapy Insights. We plan to publish a comprehensive review of current work in selection and expansion of T cells and NK cells, T cell receptor and chimeric antigen receptor gene insertion, selective T cell depletion to prevent GVHD, and suicide gene insertion.<br /><br />We hope to cover both basic, translational and clinical aspects of adoptive immune cell therapy.<br /><br /><span style="font-weight: bold;">Deadlines</span><br /><br />Registration of manuscripts: 1 May 2010<br /><br />Manuscripts submitted: 1 June 2010<br /><br />Completion of peer review: circa 1 July 2010<br /><br />Resubmission of revised manuscripts: circa 1 September 2010<br /><br /><span style="font-weight: bold;">How to participate</span><br /><br /><a href="https://www.formspring.com/forms/?764065-N8b5qIMO2O">To register your manuscript visit this page</a>. All manuscripts are subject to approval by the Editor in Chief.<br /><br /><span style="font-weight: bold;">Article processing fees</span><br /><br />Submissions are welcomed from individuals not on the editorial board. An article processing fee will be charged in recognition of the journal’s open access status.<br /><br />Editorial board members are encouraged to use their APF waiver or discount.<br /><br /><span style="font-weight: bold;">General call for papers</span><br /><br />A <a href="http://www.la-press.com/announcements-immunology-and-immunogenetics-insights-call-for-papers">general call for papers</a> was recently announced. I continue to welcome submissions to the general volume. Manuscripts may be submitted at any time.<br /><br /><br />Your sincerely,<br /><br />Dr John Barrett,<br />Editor in Chief<br /><span style="font-style: italic;">Immunotherapy Insights</span><div class="blogger-post-footer"><img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7404115720438716495-7670614155109322290?l=libertasacademica.blogspot.com' alt='' /></div><div class="feedflare"> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=oZ9SDN4XPao:1N_eXta70J4:yIl2AUoC8zA"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?d=yIl2AUoC8zA" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=oZ9SDN4XPao:1N_eXta70J4:63t7Ie-LG7Y"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?d=63t7Ie-LG7Y" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=oZ9SDN4XPao:1N_eXta70J4:7Q72WNTAKBA"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?d=7Q72WNTAKBA" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=oZ9SDN4XPao:1N_eXta70J4:V_sGLiPBpWU"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?i=oZ9SDN4XPao:1N_eXta70J4:V_sGLiPBpWU" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=oZ9SDN4XPao:1N_eXta70J4:qj6IDK7rITs"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?d=qj6IDK7rITs" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=oZ9SDN4XPao:1N_eXta70J4:TzevzKxY174"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?d=TzevzKxY174" border="0"></img></a> </div><img src="http://feeds.feedburner.com/~r/LibertasAcademica/~4/oZ9SDN4XPao" height="1" width="1"/>Tom Hillhttp://www.blogger.com/profile/14499465026739684247tom.hill@la-press.com0http://libertasacademica.blogspot.com/2009/12/proposals-invited-for-immunotherapy.htmltag:blogger.com,1999:blog-7404115720438716495.post-13498199419558637652009-12-07T15:27:00.001+13:002009-12-07T15:33:15.144+13:002009-12-07T15:33:15.144+13:00Dear colleagues,<br /><br />I invite you to submit a paper to the forthcoming special issue of <span style="font-style: italic;">Human Parasitic Diseases</span>.<br /><br /><span style="font-weight: bold;">About the special issue</span><br /><br />The theme of this special issue is ‘Novel Strategies for Malaria Control.’<br /><br />For the first time in decades, WHO reports that there is a real prospect of malaria elimination in Africa. Huge gains have been made in endemic areas through the use of longlasting insecticide treated nets (LLINs) and artemisinin-based combination therapies (ACTs), but vector and parasite resistance, respectively, threaten to undermine and perhaps even reverse these gains.<br /><br />It follows that now, as never before, there is a need for novel strategies for malaria control, and this is the focus of this special issue. We will consider all papers addressing any aspect of malaria or malaria vector reduction, but we particularly welcome papers that propose affordable, sustainable and environmentally friendly strategies that can be easily integrated into existing malaria control activities.<br /><br />Please take the time to study our Guidelines for Authors, and prepare to send us your submission now.<br /><br /><span style="font-weight: bold;">Deadlines</span><br /><br />Registration of manuscripts: 1 May 2010<br /><br />Manuscripts submitted: 1 June 2010<br /><br />Completion of peer review: circa 1 July 2010<br /><br />Resubmission of revised manuscripts: circa 1 September 2010<br /><br /><span style="font-weight: bold;">How to participate</span><br /><br /><a href="https://www.formspring.com/forms/?764065-N8b5qIMO2O">To register your manuscript visit this page</a>. All manuscripts are subject to approval by the Editor in Chief.<br /><br /><span style="font-weight: bold;">Article processing fees</span><br /><br />Submissions are welcomed from individuals not on the editorial board. An article processing fee will be charged in recognition of the journal’s open access status.<br /><br />Editorial board members are encouraged to use their APF waiver or discount.<br /><br /><span style="font-weight: bold;">General call for papers</span><br /><br />A <a href="http://www.la-press.com/announcements-human-parasitic-diseases-call-for-papers">general call for papers</a> was recently announced. I continue to welcome submissions to the general volume. Manuscripts may be submitted at any time.<br /><br /><br />Your sincerely,<br /><br />Ashley Croft, M.D.<br />Editor in Chief<br /><span style="font-style: italic;">Human Parasitic Diseases</span><div class="blogger-post-footer"><img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7404115720438716495-1349819941955863765?l=libertasacademica.blogspot.com' alt='' /></div><div class="feedflare"> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=v8yhW-1boro:7FrgqOzln0I:yIl2AUoC8zA"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?d=yIl2AUoC8zA" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=v8yhW-1boro:7FrgqOzln0I:63t7Ie-LG7Y"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?d=63t7Ie-LG7Y" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=v8yhW-1boro:7FrgqOzln0I:7Q72WNTAKBA"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?d=7Q72WNTAKBA" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=v8yhW-1boro:7FrgqOzln0I:V_sGLiPBpWU"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?i=v8yhW-1boro:7FrgqOzln0I:V_sGLiPBpWU" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=v8yhW-1boro:7FrgqOzln0I:qj6IDK7rITs"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?d=qj6IDK7rITs" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=v8yhW-1boro:7FrgqOzln0I:TzevzKxY174"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?d=TzevzKxY174" border="0"></img></a> </div><img src="http://feeds.feedburner.com/~r/LibertasAcademica/~4/v8yhW-1boro" height="1" width="1"/>Tom Hillhttp://www.blogger.com/profile/14499465026739684247tom.hill@la-press.com0http://libertasacademica.blogspot.com/2009/12/proposals-invited-for-human-parasitic.htmltag:blogger.com,1999:blog-7404115720438716495.post-57990315570583339702009-12-07T15:22:00.001+13:002009-12-07T15:26:48.382+13:002009-12-07T15:26:48.382+13:00Dear colleagues,<br /><br />I invite you to submit a paper to the forthcoming special issue of <span style="font-style: italic;">Healthy Aging and Clinical Care in the Elderly</span>.<br /><br /><span style="font-weight: bold;">About the special issue</span><br /><br />According to the current estimates, it is expected that in most developed countries, the majority of babies born since the past 10 years will reach 100 years old and older. With this continuous aging of the population associated with an increased life expectancy, knowledge and strategies contributing to delaying the occurrence of limiting disability during aging are becoming central in the management of the aging population.<br /><br />This special issue will specifically give priority to manuscript that focus on the development of a better understanding and novel strategies that can improve early diagnosis and prevention of age-related conditions.<br /><br /><span style="font-weight: bold;">Deadlines</span><br /><br />Registration of manuscripts: 1 May 2010<br /><br />Manuscripts submitted: 1 June 2010<br /><br />Completion of peer review: circa 1 July 2010<br /><br />Resubmission of revised manuscripts: circa 1 September 2010<br /><br /><span style="font-weight: bold;">How to participate</span><br /><br /><a href="https://www.formspring.com/forms/?764065-N8b5qIMO2O">To register your manuscript visit this page</a>. All manuscripts are subject to approval by the Editor in Chief.<br /><br /><span style="font-weight: bold;">Article processing fees</span><br /><br />Submissions are welcomed from individuals not on the editorial board. An article processing fee will be charged in recognition of the journal’s open access status.<br /><br />Editorial board members are encouraged to use their APF waiver or discount.<br /><br /><span style="font-weight: bold;">General call for papers</span><br /><br />A <a href="http://www.la-press.com/announcements-healthy-aging-clinical-care-in-the-elderly-call-for-papers">general call for papers</a> was recently announced. I continue to welcome submissions to the general volume. Manuscripts may be submitted at any time.<br /><br /><br />Your sincerely,<br /><br />Dr David Simar,<br />Editor in Chief<br /><span style="font-style: italic;">Healthy Aging and Clinical Care in the Elderly</span><div class="blogger-post-footer"><img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7404115720438716495-5799031557058333970?l=libertasacademica.blogspot.com' alt='' /></div><div class="feedflare"> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=_uwhPs4NCPY:vGsctPn_Z1c:yIl2AUoC8zA"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?d=yIl2AUoC8zA" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=_uwhPs4NCPY:vGsctPn_Z1c:63t7Ie-LG7Y"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?d=63t7Ie-LG7Y" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=_uwhPs4NCPY:vGsctPn_Z1c:7Q72WNTAKBA"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?d=7Q72WNTAKBA" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=_uwhPs4NCPY:vGsctPn_Z1c:V_sGLiPBpWU"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?i=_uwhPs4NCPY:vGsctPn_Z1c:V_sGLiPBpWU" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=_uwhPs4NCPY:vGsctPn_Z1c:qj6IDK7rITs"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?d=qj6IDK7rITs" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=_uwhPs4NCPY:vGsctPn_Z1c:TzevzKxY174"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?d=TzevzKxY174" border="0"></img></a> </div><img src="http://feeds.feedburner.com/~r/LibertasAcademica/~4/_uwhPs4NCPY" height="1" width="1"/>Tom Hillhttp://www.blogger.com/profile/14499465026739684247tom.hill@la-press.com0http://libertasacademica.blogspot.com/2009/12/proposals-invited-for-healthy-aging-and.htmltag:blogger.com,1999:blog-7404115720438716495.post-57408672449202034522009-12-07T15:13:00.002+13:002009-12-07T15:16:58.739+13:002009-12-07T15:16:58.739+13:00Dear colleagues,<br /><br />I invite you to submit a paper to the forthcoming special issue of <span style="font-style: italic;">Genomics Insights</span> on Next-generation Sequencing, which will be edited by Dr. Mathew Hudson (University of Illinois).<br /><br /><span style="font-weight: bold;">About the special issue</span><br /><br />Next-generation sequencing is revolutionizing how biologists and biotechnologists are acquiring sequence information for basic and applied biological research. These technologies use novel chemistries, microfluidic systems, and reaction detection procedures that increase throughput of shorter reads at considerably less cost. Next-generation sequencing is driving research growth and developments in many fields, including biomedicine, food and agriculture research, and bioengineering, with profound impact on genomic biology.<br /><br />However, the generation of terabytes of data per run poses a gigantic bioinformatic challenge that needs to be addressed appropriately. Moreover, a rising number of next-generation sequencing applications are now possible in fields that seem unlikely, ranging from cancer research to analysis of small and regulatory RNA molecules.<br /><br />Potential applications are as numerous as the samples that can be analyzed, but are restricted by the next-generation platform and its optimization. The special issue will focus both on the technology and its challenges and on its application.<br /><br />Research areas that are particularly encouraged are:<br /><br /><span style="font-style: italic;">Technology:</span> De novo sequencing and resequencing of DNA and RNA. Contrasting of next-generation sequencing platforms. Bioinformatics, statistical and computational challenges related to next-generation sequencing technologies, including developments of algorithms and computational tools.<br /><br /><span style="font-style: italic;">Applications:</span> Characterization of sequence diversity (such as genotyping and SNP mapping and discovery), analysis of gene copy number, chromosomal rearrangements, and gene expression, applications in epigenetics and cancer research, exploration of interactions between and within proteins and nucleic acids, targeted resequencing, and digital gene expression.<br /><br /><span style="font-weight: bold;">Deadlines</span><br /><br />Registration of manuscripts: 1 May 2010<br /><br />Manuscripts submitted: 1 June 2010<br /><br />Completion of peer review: circa 1 July 2010<br /><br />Resubmission of revised manuscripts: circa 1 September 2010<br /><br /><span style="font-weight: bold;">How to participate</span><br /><br /><a href="https://www.formspring.com/forms/?764065-N8b5qIMO2O">To register your manuscript visit this page</a>. All manuscripts are subject to approval by the Editor in Chief.<br /><br /><span style="font-weight: bold;">Article processing fees</span><br /><br />Submissions are welcomed from individuals not on the editorial board. An article processing fee will be charged in recognition of the journal’s open access status.<br /><br />Editorial board members are encouraged to use their APF waiver or discount.<br /><br /><span style="font-weight: bold;">General call for papers</span><br /><br />A <a href="http://www.la-press.com/announcements-genomics-insights-call-for-papers">general call for papers</a> was recently announced. I continue to welcome submissions to the general volume. Manuscripts may be submitted at any time.<br /><br /><br />Your sincerely,<br /><br />Gustavo Caetano,<br />Editor in Chief<br /><span style="font-style: italic;">Genomics Insights</span><div class="blogger-post-footer"><img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7404115720438716495-5740867244920203452?l=libertasacademica.blogspot.com' alt='' /></div><div class="feedflare"> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=1Hw-udMcdYE:gPHKlBaVErc:yIl2AUoC8zA"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?d=yIl2AUoC8zA" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=1Hw-udMcdYE:gPHKlBaVErc:63t7Ie-LG7Y"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?d=63t7Ie-LG7Y" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=1Hw-udMcdYE:gPHKlBaVErc:7Q72WNTAKBA"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?d=7Q72WNTAKBA" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=1Hw-udMcdYE:gPHKlBaVErc:V_sGLiPBpWU"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?i=1Hw-udMcdYE:gPHKlBaVErc:V_sGLiPBpWU" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=1Hw-udMcdYE:gPHKlBaVErc:qj6IDK7rITs"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?d=qj6IDK7rITs" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=1Hw-udMcdYE:gPHKlBaVErc:TzevzKxY174"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?d=TzevzKxY174" border="0"></img></a> </div><img src="http://feeds.feedburner.com/~r/LibertasAcademica/~4/1Hw-udMcdYE" height="1" width="1"/>Tom Hillhttp://www.blogger.com/profile/14499465026739684247tom.hill@la-press.com0http://libertasacademica.blogspot.com/2009/12/proposals-invited-for-genomics-insights.htmltag:blogger.com,1999:blog-7404115720438716495.post-39527182531247521982009-12-07T15:03:00.004+13:002009-12-07T15:17:25.166+13:002009-12-07T15:17:25.166+13:00Dear colleagues,<br /><br />I invite you to submit a paper to the forthcoming special issue of <span style="font-style: italic;">Genetics and Epigenetics</span>.<br /><br /><span style="font-weight: bold;">About the special issue</span><br /><br />On behalf of the Editorial Board, it is a pleasure to invite you to submit a manuscript for publication in a special issue of <span style="font-style: italic;">Genetics and Epigenetics</span> for 2010.<br /><br />This special issue will concern a particular aspect of Epigenetics with a focus on the mechanisms of the epigenetic code inheritance. This concerns the inheritance from a mother to the daughter cells but also from generation to generation in various organisms, plants, human, and animals.<br /><br />Papers, including original studies, short reports, reviews, point of views, commentaries, technical reports, concerning the molecular mechanisms of the transmission of the epigenetic marks to the descent will be considered.<br /><br />For instance, here is a non-exhaustive list of some aspects that are encouraged to be discussed or investigated:<br /><ul><li>mechanisms underlying chromatin dynamics during DNA replication in eukaryotic cells<br /><br /></li><li>maintenance of epigenetic marks<br /><br /></li><li>nucleosome assembly during DNA replication<br /><br /></li><li>post-translational modifications of histones that are conserved during mitosis<br /><br /></li><li>DNA hemi-methylation recognition<br /><br /></li><li>silencing mechanism controlling development and parent-of-origin imprinted gene expression<br /><br /></li><li>signalling pathways regulating all these processes<br /><br /></li><li>transgenerational epigenetic modifications to environmental stimuli</li></ul><span style="font-weight: bold;">Deadlines</span><br /><ul><li>Registration of manuscripts: 1 May 2010<br /><br /></li><li>Manuscripts submitted: 1 June 2010<br /><br /></li><li>Completion of peer review: circa 1 July 2010<br /><br /></li><li>Resubmission of revised manuscripts: circa 1 September 2010</li></ul><span style="font-weight: bold;">How to participate</span><br /><br /><a href="https://www.formspring.com/forms/?764065-N8b5qIMO2O">To register your manuscript visit this page</a>. All manuscripts are subject to approval by the Editor in Chief.<br /><br /><span style="font-weight: bold;">Article processing fees</span><br /><br />Submissions are welcomed from individuals not on the editorial board. An article processing fee will be charged in recognition of the journal’s open access status.<br /><br />Editorial board members are encouraged to use their APF waiver or discount.<br /><br /><span style="font-weight: bold;">General call for papers</span><br /><br />A <a href="http://www.la-press.com/announcements-genetics-epigenetics-call-for-papers">general call for papers</a> was recently announced. I continue to welcome submissions to the general volume. Manuscripts may be submitted at any time.<br /><br /><br />Your sincerely,<br /><br />Dr Christian Bronner<br />Editor in Chief<br /><span style="font-style: italic;">Genetics and Epigenetics<br /></span><div class="blogger-post-footer"><img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7404115720438716495-3952718253124752198?l=libertasacademica.blogspot.com' alt='' /></div><div class="feedflare"> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=Ox_jWPrrR7A:TcgHQhGFxos:yIl2AUoC8zA"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?d=yIl2AUoC8zA" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=Ox_jWPrrR7A:TcgHQhGFxos:63t7Ie-LG7Y"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?d=63t7Ie-LG7Y" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=Ox_jWPrrR7A:TcgHQhGFxos:7Q72WNTAKBA"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?d=7Q72WNTAKBA" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=Ox_jWPrrR7A:TcgHQhGFxos:V_sGLiPBpWU"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?i=Ox_jWPrrR7A:TcgHQhGFxos:V_sGLiPBpWU" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=Ox_jWPrrR7A:TcgHQhGFxos:qj6IDK7rITs"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?d=qj6IDK7rITs" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=Ox_jWPrrR7A:TcgHQhGFxos:TzevzKxY174"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?d=TzevzKxY174" border="0"></img></a> </div><img src="http://feeds.feedburner.com/~r/LibertasAcademica/~4/Ox_jWPrrR7A" height="1" width="1"/>Tom Hillhttp://www.blogger.com/profile/14499465026739684247tom.hill@la-press.com0http://libertasacademica.blogspot.com/2009/12/proposals-invited-for-genetics-and.htmltag:blogger.com,1999:blog-7404115720438716495.post-85200279619651422432009-12-04T17:23:00.001+13:002009-12-04T17:25:41.381+13:002009-12-04T17:25:41.381+13:00Dear colleagues,<br /><br />I invite you to submit a paper to the forthcoming special issue of <span style="font-style: italic;">Environmental Health Insights</span>.<br /><br /><span style="font-weight: bold;">About the special issue</span><br /><br />Global climate change is now recognized as a serious threat to the well-being and survival of humans and other organisms. This is a topic that relates to almost every aspect of the discipline of environmental health. These aspects include epidemiology and infectious disease control (e.g., expansion of pests and related disease from traditionally-limited geographic areas); air quality (e.g., carbon emissions); water quality (e.g. sea level rise); emergency management (e.g., hurricanes, floods, etc.); agriculture (crop range limitation and changing plant pathogen threats); the public and science’s perception of climate change and their interaction; and a wide range of others.<br /><br />This special issue provides an opportunity for authors to submit manuscripts for consideration of publication of diverse topics related to global climate change. Since the term “insights” implies the inclusion of ideas that may have not previously been considered, I invite authors to use their creative skills to identify new connections of environmental health to global climate change. This may include new developments in the field of environmental health related to climate change, new approaches or applications dealing with climate change issues, economic disparities in environmental health services related to climate change, or changing public opinions and scientific views on climate change.<br /><br />Environmental health practitioners and researchers strive to identify, prevent, limit and/or control hazards in our environment and associated risks of exposure. Although the future problems resulting from global climate change are still uncertain, environmental health professionals continue to anticipate, evaluate, communicate and quickly respond to related to climate change hazards and risks. <br /><br />Communicating their efforts through the open-access format of <span style="font-style: italic;">Environmental Health Insights</span> with each other and the public is an important accomplishment towards achieving this goal.<br /><br /><span style="font-weight: bold;">Deadlines</span><br /><ul><li>Registration of manuscripts: 1 May 2010<br /><br /></li><li>Manuscripts submitted: 1 June 2010<br /><br /></li><li>Completion of peer review: circa 1 July 2010<br /><br /></li><li>Resubmission of revised manuscripts: circa 1 September 2010</li></ul><span style="font-weight: bold;">How to participate</span><br /><br /><a href="https://www.formspring.com/forms/?764065-N8b5qIMO2O">To register your manuscript visit this page</a>. All manuscripts are subject to approval by the Editor in Chief.<br /><br /><span style="font-weight: bold;">Article processing fees</span><br /><br />Submissions are welcomed from individuals not on the editorial board. An article processing fee will be charged in recognition of the journal’s open access status.<br /><br />Editorial board members are encouraged to use their APF waiver or discount.<br /><br /><span style="font-weight: bold;">General call for papers</span><br /><br />A <a href="http://www.la-press.com/announcements-environmental-health-insights-call-for-papers">general call for papers</a> was recently announced. I continue to welcome submissions to the general volume. Manuscripts may be submitted at any time.<br /><br /><br />Your sincerely,<br /><br />Timothy R. Kelley. Ph.D. and Professor,<br />Editor in Chief<br /><span style="font-style: italic;">Environmental Health Insights</span><div class="blogger-post-footer"><img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7404115720438716495-8520027961965142243?l=libertasacademica.blogspot.com' alt='' /></div><div class="feedflare"> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=iRCYM7G6rAw:jCTUUbWIVA0:yIl2AUoC8zA"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?d=yIl2AUoC8zA" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=iRCYM7G6rAw:jCTUUbWIVA0:63t7Ie-LG7Y"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?d=63t7Ie-LG7Y" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=iRCYM7G6rAw:jCTUUbWIVA0:7Q72WNTAKBA"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?d=7Q72WNTAKBA" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=iRCYM7G6rAw:jCTUUbWIVA0:V_sGLiPBpWU"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?i=iRCYM7G6rAw:jCTUUbWIVA0:V_sGLiPBpWU" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=iRCYM7G6rAw:jCTUUbWIVA0:qj6IDK7rITs"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?d=qj6IDK7rITs" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=iRCYM7G6rAw:jCTUUbWIVA0:TzevzKxY174"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?d=TzevzKxY174" border="0"></img></a> </div><img src="http://feeds.feedburner.com/~r/LibertasAcademica/~4/iRCYM7G6rAw" height="1" width="1"/>Tom Hillhttp://www.blogger.com/profile/14499465026739684247tom.hill@la-press.com0http://libertasacademica.blogspot.com/2009/12/proposals-invited-for-environmental.htmltag:blogger.com,1999:blog-7404115720438716495.post-69634610654410543922009-12-04T17:09:00.003+13:002009-12-04T17:19:39.117+13:002009-12-04T17:19:39.117+13:00Dear colleagues,<br /><br />I invite you to submit a paper to the forthcoming special issue of <span style="font-style: italic;">Cell and Tissue Transplantation and Therapy</span>.<br /><br /><span style="font-weight: bold;">About the special issue</span><br /><br />This special issue will be concerned with “Tissue-specific stem cells and potential use in regenerative medicine and tissue engineering". <br /><br />Much has been written concerning the potential of embryonic and induced pluripotential stem cells for clinical application. However, other types of stem cells either have made or are quickly making their way into the clinic. <br /><br />This special edition will be focused on delineating those advances. To that end we encourage researchers to submit papers dealing with the following topics.<br /><br />1. Neural stem cells (including RPE cells) for the treatment of <ul><li>Traumatic brain injury</li><li>Stroke</li><li>Parkinson’s disease</li><li>Alzheimer’s disease</li></ul>2. Adipose stem cells for use in<br /><ul><li>Orthopedic applications including bone, cartilage and ligaments</li><li>Cardiovascular disease<br /></li></ul>3. Cardiac stem cells for the treatment of<br /><ul><li>MI</li><li>Heart failure</li></ul>4. Skeletal muscle (e.g., satellite) stem cells for use in<br /><ul><li>Muscular dystrophy and other such applications</li></ul>5. Liver stem cells<br /><br />Other types of tissue-specific stem cells and their applications are also welcome.<br /><br /><span style="font-weight: bold;">Deadlines</span><br /><ul><li>Registration of manuscripts: 1 May 2010<br /><br /></li><li>Manuscripts submitted: 1 June 2010<br /><br /></li><li>Completion of peer review: circa 1 July 2010<br /><br /></li><li>Resubmission of revised manuscripts: circa 1 September 2010</li></ul><span style="font-weight: bold;">How to participate</span><br /><br />To register your manuscript visit this page. All manuscripts are subject to approval by the Editor in Chief.<br /><br /><span style="font-weight: bold;">Article processing fees</span><br /><br />Submissions are welcomed from individuals not on the editorial board. An article processing fee will be charged in recognition of the journal’s open access status.<br /><br />Editorial board members are encouraged to use their APF waiver or discount.<br /><br /><span style="font-weight: bold;">General call for papers</span><br /><br />A <a href="http://www.la-press.com/announcements-cell-tissue-transplantation-therapy-call-for-papers">general call for papers</a> was recently announced. I continue to welcome submissions to the general volume. Manuscripts may be submitted at any time.<br /><br /><br />Yours sincerely,<br /><br />David T. Harris, Ph.D.<br />Editor in Chief<br /><span style="font-style: italic;">Cell and Tissue Transplantation and Therapy</span><div class="blogger-post-footer"><img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7404115720438716495-6963461065441054392?l=libertasacademica.blogspot.com' alt='' /></div><div class="feedflare"> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=95OeQRh72Bg:nEECbpKKs3o:yIl2AUoC8zA"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?d=yIl2AUoC8zA" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=95OeQRh72Bg:nEECbpKKs3o:63t7Ie-LG7Y"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?d=63t7Ie-LG7Y" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=95OeQRh72Bg:nEECbpKKs3o:7Q72WNTAKBA"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?d=7Q72WNTAKBA" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=95OeQRh72Bg:nEECbpKKs3o:V_sGLiPBpWU"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?i=95OeQRh72Bg:nEECbpKKs3o:V_sGLiPBpWU" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=95OeQRh72Bg:nEECbpKKs3o:qj6IDK7rITs"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?d=qj6IDK7rITs" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=95OeQRh72Bg:nEECbpKKs3o:TzevzKxY174"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?d=TzevzKxY174" border="0"></img></a> </div><img src="http://feeds.feedburner.com/~r/LibertasAcademica/~4/95OeQRh72Bg" height="1" width="1"/>Tom Hillhttp://www.blogger.com/profile/14499465026739684247tom.hill@la-press.com0http://libertasacademica.blogspot.com/2009/12/proposals-invited-for-cell-and-tissue.htmltag:blogger.com,1999:blog-7404115720438716495.post-45772040559174568782009-12-04T16:57:00.001+13:002009-12-04T17:01:00.305+13:002009-12-04T17:01:00.305+13:00Dear colleagues,<br /><br />I invite you to submit a paper to the forthcoming special issue of <span style="font-style: italic;">Bone and Tissue Regeneration Insights.</span><br /><br /><span style="font-weight: bold;">About the special issue</span><br /><br />Nanomedicine has been described as having limitless potential for future medicine and aims to improve both the quality and quantity of human health. The last few years has seen a huge amount of investment and an increase in peer reviewed publications. Recent developments have shown a role for nanomedicine in a number of organs and tissues such as in bone, nerve, scaffolds and tissue engineering, with a further role for nanomedicine being identified in a number of chronic diseases such as osteoarthritis, diabetes as well as diseases of the central nervous system. <br /><br />Nanomedicine has been shown to have potential in understanding cellular function and interactions, drug delivery and in new and exciting scaffolds, its role with stem cells and in regenerating tissue themselves. This special issue aims to cover the roles and potential roles that nanomedicine has in regeneration in all organs and tissues. This special issue aims to show the theoretical limitless potential of nanomedicine in regeneration. We are interested in all nanomedicine topics in relation to regeneration.<br /><br /><span style="font-weight: bold;">Deadlines</span><br /><ul><li>Registration of manuscripts: 1 May 2010<br /><br /></li><li>Manuscripts submitted: 1 June 2010<br /><br /></li><li>Completion of peer review: circa 1 July 2010<br /><br /></li><li>Resubmission of revised manuscripts: circa 1 September 2010</li></ul><span style="font-weight: bold;">How to participate</span><br /><br /><a href="https://www.formspring.com/forms/?764065-N8b5qIMO2O">To register your manuscript visit this page</a>. All manuscripts are subject to approval by the Editor in Chief.<br /><br /><span style="font-weight: bold;">Article processing fees</span><br /><br />Submissions are welcomed from individuals not on the editorial board. An article processing fee will be charged in recognition of the journal’s open access status.<br /><br />Editorial board members are encouraged to use their APF waiver or discount.<br /><br /><span style="font-weight: bold;">General call for papers</span><br /><br />A <a href="http://www.la-press.com/announcements-bone-and-tissue-regeneration-insights-call-for-papers">general call for papers</a> was recently announced. I continue to welcome submissions to the general volume. Manuscripts may be submitted at any time.<br /><br /><br />Yours sincerely,<br /><br />Kerstin Rolfe,<br />Editor in Chief<br /><span style="font-style: italic;">Bone and Tissue Regeneration Insights</span><div class="blogger-post-footer"><img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7404115720438716495-4577204055917456878?l=libertasacademica.blogspot.com' alt='' /></div><div class="feedflare"> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=_OvfsRoj6nM:Dt9cjKsrIpo:yIl2AUoC8zA"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?d=yIl2AUoC8zA" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=_OvfsRoj6nM:Dt9cjKsrIpo:63t7Ie-LG7Y"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?d=63t7Ie-LG7Y" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=_OvfsRoj6nM:Dt9cjKsrIpo:7Q72WNTAKBA"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?d=7Q72WNTAKBA" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=_OvfsRoj6nM:Dt9cjKsrIpo:V_sGLiPBpWU"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?i=_OvfsRoj6nM:Dt9cjKsrIpo:V_sGLiPBpWU" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=_OvfsRoj6nM:Dt9cjKsrIpo:qj6IDK7rITs"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?d=qj6IDK7rITs" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=_OvfsRoj6nM:Dt9cjKsrIpo:TzevzKxY174"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?d=TzevzKxY174" border="0"></img></a> </div><img src="http://feeds.feedburner.com/~r/LibertasAcademica/~4/_OvfsRoj6nM" height="1" width="1"/>Tom Hillhttp://www.blogger.com/profile/14499465026739684247tom.hill@la-press.com0http://libertasacademica.blogspot.com/2009/12/proposals-invited-for-bone-and-tissue.htmltag:blogger.com,1999:blog-7404115720438716495.post-70103944977439058482009-12-04T16:47:00.002+13:002009-12-04T16:56:58.953+13:002009-12-04T16:56:58.953+13:00Dear colleagues,<br /><br />I invite you to submit a paper to the forthcoming special issue of <span style="font-style: italic;">Biochemistry Insights</span>. The title of the special issue is “Proteins and enzymes in disease and health”.<br /><br /><span style="font-weight: bold;">About the special issue</span><br /><br />This special issue will focus on advances, challenges, and directions in protein biochemistry with emphasis on enzymes involved in cancer, diabetes, cardiovascular and other diseases. Although proteins and enzymes have long been known as essential to normal cell life, awareness of their therapeutic potentials has considerably increased in recent years. Researchers in this field are taking steps forward in biochemistry and pharmacology of enzymes, regulation of cellular functions and growth by proteins, and mechanism-based drug discovery and drug development.<br /><br />Just to mention a few more examples, we may point to cell signalling, programmed cell death, and the trafficking and processing of proteins. The special issue will cover a broadly defined conception of molecular biochemical aetiology. Topics may include, but are not limited to, the following:<br /><ul><li>Identities and roles of proteins and enzymes in normal and pathological processes</li><li>Advances in enzymology and enzyme regulation</li><li>Modes of action and molecular mechanisms by which proteins and enzymes alter pathogenesis</li><li>Enzyme inhibitors and biologically active compounds that target cell signalling and metabolic pathways relevant to treatment and improvement of diseases</li><li>Disease targeting by means of proteins and enzymes</li><li>Proteins and enzymes in drug development and biomedicine</li><li>Enzyme therapy and utility of proteins for disease prevention and treatment</li><li>Safety, concerns, and perspectives of enzyme therapy</li><li>Experimental approaches, methodological advances, and new strategies in protein and enzyme analysis including mass spectrometry, microarrays technology, fluorescence and nuclear magnetic resonance spectroscopy, and x-ray diffraction. </li></ul>The editorial team encourages you to submit all forms of scholarly articles, such as original research reports, conceptual papers, reviews, and commentaries that help to illuminate any aspects of this immense and evolving field.<br /><br />If your work does not fit into one of the topics listed above, but is still in the wide area of protein and enzyme research, just submit your manuscript and we will appropriately review it. We look forward to your contribution to this timely and important issue of <span style="font-style: italic;">Biochemistry Insights</span>.<br /><br /><span style="font-weight: bold;">Deadlines</span><br /><ul><li>Registration of manuscripts: 1 May 2010<br /><br /></li><li>Manuscripts submitted: 1 June 2010<br /><br /></li><li>Completion of peer review: circa 1 July 2010<br /><br /></li><li>Resubmission of revised manuscripts: circa 1 September 2010</li></ul><span style="font-weight: bold;">How to participate</span><br /><br /><a href="https://www.formspring.com/forms/?764065-N8b5qIMO2O">To register your manuscript visit this page</a>. All manuscripts are subject to approval by the Editor in Chief.<br /><br /><span style="font-weight: bold;">Article processing fees</span><br /><br />Submissions are welcomed from individuals not on the editorial board. An article processing fee will be charged in recognition of the journal’s open access status.<br /><br />Editorial board members are encouraged to use their APF waiver or discount.<br /><br /><span style="font-weight: bold;">General call for papers</span><br /><br />A <a href="http://www.la-press.com/announcements-biochemistry-insights-call-for-papers">general call for papers</a> was recently announced. I continue to welcome submissions to the general volume. Manuscripts may be submitted at any time.<br /><br /><br />Your sincerely,<br /><br />Gabor Mocz, Ph.D.,<br />Editor in Chief<br /><span style="font-style: italic;">Biochemistry Insights</span><div class="blogger-post-footer"><img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/7404115720438716495-7010394497743905848?l=libertasacademica.blogspot.com' alt='' /></div><div class="feedflare"> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=-GHbVIX0qWQ:7TsDiD92RJk:yIl2AUoC8zA"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?d=yIl2AUoC8zA" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=-GHbVIX0qWQ:7TsDiD92RJk:63t7Ie-LG7Y"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?d=63t7Ie-LG7Y" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=-GHbVIX0qWQ:7TsDiD92RJk:7Q72WNTAKBA"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?d=7Q72WNTAKBA" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=-GHbVIX0qWQ:7TsDiD92RJk:V_sGLiPBpWU"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?i=-GHbVIX0qWQ:7TsDiD92RJk:V_sGLiPBpWU" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=-GHbVIX0qWQ:7TsDiD92RJk:qj6IDK7rITs"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?d=qj6IDK7rITs" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/LibertasAcademica?a=-GHbVIX0qWQ:7TsDiD92RJk:TzevzKxY174"><img src="http://feeds.feedburner.com/~ff/LibertasAcademica?d=TzevzKxY174" border="0"></img></a> </div><img src="http://feeds.feedburner.com/~r/LibertasAcademica/~4/-GHbVIX0qWQ" height="1" width="1"/>Tom Hillhttp://www.blogger.com/profile/14499465026739684247tom.hill@la-press.com0http://libertasacademica.blogspot.com/2009/12/proposals-invited-for-biochemistry.html